Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 13–13 | Cite as

Adalimumab

Various toxicities: 7 case reports
Case report
  • 21 Downloads

Reference

  1. Kamat N, et al. Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study. Indian Journal of Gastroenterology 38: 44-54, No. 1, Feb 2019. Available from: URL: http://doi.org/10.1007/s12664-018-0922-1 - India

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations